Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Matthew M ZipseWendy S TzouJoseph L SchullerRyan G AleongPaul D VarosyChristine TompkinsRyan T BorneAlexis Z TumoloAmneet SandhuDarlene KimAndrew M FreemanHoward D WeinbergerLisa A MaierRaphael K SungDuy T NguyenWilliam H SauerPublished in: Journal of cardiovascular electrophysiology (2019)
EPS is useful in the risk stratification of patients with probable CS with preserved LV and RV function. A positive EPS was associated with VAs. While a negative EPS appeared to confer low risk, close follow-up is needed as EPS cannot predict fatal VAs related to new cardiac involvement or disease progression.